Dmitri V. Lissin
Chief Tech/Sci/R&D Officer en SCILEX HOLDING COMPANY .
Perfil
Dmitri V.
Lissin is currently the Director & Chief Medical Officer at Semnur Pharmaceuticals, Inc. He is also the Chief Medical Officer & Senior Vice President at Scilex, Inc. and Scilex Holding Co. Previously, he served as the Vice President-Clinical Development at XenoPort, Inc. from 2011 to 2015.
Dr. Lissin holds a doctorate degree from the Russian National Research Medical University.
Cargos activos de Dmitri V. Lissin
| Empresas | Cargo | Inicio |
|---|---|---|
| SCILEX HOLDING COMPANY | Chief Tech/Sci/R&D Officer | - |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | 01/07/2015 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Chief Tech/Sci/R&D Officer | 01/03/2019 |
Antiguos cargos conocidos de Dmitri V. Lissin.
| Empresas | Cargo | Fin |
|---|---|---|
| XENOPORT, INC. | Chief Tech/Sci/R&D Officer | 01/08/2015 |
Formación de Dmitri V. Lissin.
| Russian National Research Medical University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Empresas privadas | 3 |
|---|---|
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Dmitri V. Lissin
